Request a Trial
Hoodin is specifically designed to perform monitoring for a life science product throughout their entire life cycle. With Hoodin, you have the flexibility to set up monitoring for a specific product (brand name) or a product type (such as a device, IVD product, or drug.) The trial project you will have access to will be customized to monitor the product or product type of your preference.
You will get access to a 14- day free trial of Hoodin
Request a Trial
Hoodin is specifically designed to perform monitoring for a life science product throughout their entire life cycle. With Hoodin, you have the flexibility to set up monitoring for a specific product (brand name) or a product type (such as a device, IVD product, or drug.) The trial project you will have access to will be customized to monitor the product or product type of your preference.
You will get access to a 14- day free trial of Hoodin
Request a Trial
Hoodin is specifically designed to perform monitoring for a life science product throughout their entire life cycle. With Hoodin, you have the flexibility to set up monitoring for a specific product (brand name) or a product type (such as a device, IVD product, or drug.) The trial project you will have access to will be customized to monitor the product or product type of your preference.
You will get access to a 14- day free trial of Hoodin
Financial information
Financial calendar
Don't miss out on any important happenings.
Årsredovisning 2024 - Vecka 15 2025
Delårsrapport Q1 - 30/4 2025
Årsstämma - 14/5 2025
Reports
Only available in Swedish
Interim Q1 2024
Year-end and interim Q4 2023
Interim Q3 2020
Interim Q2 2020
Annual reports
Only available in Swedish
Board
Hans-Peter Ostler
Chairman
Hans-Peter has more than 20 years of experience from investment and private banking in Swedbank, UBS, Danske Bank and Söderberg & Partners combined with experience of board work, in both listed and unlisted companies, mainly in innovation-driven activities such as Life Science, Tech and Greentech.
Martin King
Independent board member
Martin King, a British/Swiss national, brings over 40 years of extensive global experience in quality assurance, regulatory affairs, operational management, and leadership. With an educational background in Electronics, Software as a Medical Device, Mechanical Engineering, and Materials Science, Martin has worked across the complete value-chain of the Medical Device, In Vitro Diagnostics, and Pharmaceutical industry. As an independent consultant, Martin helps companies successfully approve their products and maximize their businesses by applying quality assurance and regulatory affairs throughout the product life-cycle.
Per Bengtsson
Board member
Per Bengtsson has 20 years of experience in banking and finance, primarily within Private Banking at SEB in Luxembourg and Singapore and Danske Bank in Sweden. Nowadays, Per works as Investment Manager for Alsteron AB, which is a Family Office and who invest in both well-listed and unlisted companies.
Mattias Berntsson
Board member
Mattias is an advisor within corporate finance focused on primarily Nordic sustainable growth companies within healthtech, greentech and industrial tech. Mattias has more than 20 years of combined international and local investment and financing experience from different positions in private as well as public institutions. Previous responsibilities include ABB, Swiss Re, Pantheon and VGR.
Marcus Emne
Board member & CEO
Marcus Emne (born 1973) is the founder of Hoodin. In addition, Emne has extensive experience of international business building, including managing director of BTS (Nasdaq Stockholm) operations within Interactive and manager of Sales & Marketing Services at CGI. Emne has also held the position as responsible for Corporate Development & Strategy at Sony Mobile.
Election committee
Hans-Peter Ostler
Jari Pulkkinen
Per Bengtsson
Henrik Jerner